Navigation Links
Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber
Date:8/27/2008

and time course of sublingual immunotherapy (SLIT) administered as 300IR allergen-based tablets once daily to 86 adults suffering from grass pollen rhinoconjunctivitis. The main objectives of the study were to assess the efficacy of grass pollen extract SLIT tablets compared to placebo on the average Rhinoconjunctivitis Total Symptom Score (sneezing, rhinorrhea, nasal pruritus, nasal congestion, ocular pruritus and watery eyes), to evaluate the onset of action after different treatment durations (1 week, 1 month, 2 and 4 months) through the challenge test, to identify immunological parameters as possible biomarkers for SLIT, and to assess safety. Since patients were not allowed to take any rescue medication, the symptom score was not impacted by its usage and the difference between the placebo and active group was due exclusively to the effect of the Oralair(R) Grasses tablet.

ABOUT THE ALLERGEN CHALLENGE CHAMBER (ACC)

The Allergen Challenge Chamber is already recognized as a supportive study by the FDA and the European Medicines Agency (EMEA). The interest of ACC as an assessment tool for clinical development is confirmed. The Allergen Challenge Chamber (ACC) offsets the unpredictability of the pollen season, and thereby avoids the variable nature of pollens and patient exposure and facilitates follow up.

About oralair(R) Grasses

Oralair(R) Grasses is a fast-dissolving tablet that has demonstrated high efficacy in treating allergic rhinoconjunctivitis to grass pollen starting with the first season, lasting throughout the pollen season, and at the pollen peak, on:

- Poly- and mono-sensitised patients, as well as asthmatic

patients,

- Every individual symptom, and in particular on nasal

congestion and watery eyes.

Oralair(R) Grasses is a pre-seasonal treatment: it has to be started four months before the pollen season, be maintained throughout the season, and then stopped and restarted the following s
'/>"/>

SOURCE Stallergenes
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing
2. Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events
3. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
4. BioVex Announces Regulatory Clearance to Commence a Clinical Study With ImmunoVEX HSV2; A Vaccine Candidate for Genital Herpes
5. febit and TGen Collaborate to Study New DNA Capture Method
6. Study Shows Benefits of a High Omega-3 Diet in Older Adults
7. NewCardio Announces Positive Results From Third Clinical Validation Study
8. M. D. Anderson to Initiate Clinical Validation Study on Rosetta Genomics MicroRNA-based Diagnostic Assay Identifying the Origin of Cancer Metastases
9. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
10. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
11. Icon Bioscience Completes Enrollment in Phase I Study of Novel Ophthalmic Drug Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 2015  IDEXX Laboratories, Inc. (NASDAQ: IDXX ) ... of $413 million, an increase of 6% compared to ... the US dollar reduced reported revenue growth by 7%. ... was 11%, supported by strong growth in the Companion ... ("EPS") was $0.60 for the quarter, an increase of ...
(Date:7/29/2015)... 2015  Astellas today announced topline results from ... and safety of intravenous (IV) and oral isavuconazole, ... for adults with candidemia and other invasive ... that the trial did not meet its primary ... isavuconazole-treated patients at the end of IV therapy ...
(Date:7/29/2015)... , July 29, 2015  Unilife Corporation ("Unilife" ... UNS), a developer, manufacturer and supplier of injectable drug ... financing strategy that provides the Company with flexibility and ... Unilife has signed an equity purchase agreement for ... LLC ("LPC"), a Chicago -based institutional ...
Breaking Medicine Technology:IDEXX Laboratories Announces Second Quarter Results 2IDEXX Laboratories Announces Second Quarter Results 3IDEXX Laboratories Announces Second Quarter Results 4IDEXX Laboratories Announces Second Quarter Results 5IDEXX Laboratories Announces Second Quarter Results 6IDEXX Laboratories Announces Second Quarter Results 7IDEXX Laboratories Announces Second Quarter Results 8IDEXX Laboratories Announces Second Quarter Results 9IDEXX Laboratories Announces Second Quarter Results 10IDEXX Laboratories Announces Second Quarter Results 11IDEXX Laboratories Announces Second Quarter Results 12IDEXX Laboratories Announces Second Quarter Results 13IDEXX Laboratories Announces Second Quarter Results 14IDEXX Laboratories Announces Second Quarter Results 15IDEXX Laboratories Announces Second Quarter Results 16IDEXX Laboratories Announces Second Quarter Results 17IDEXX Laboratories Announces Second Quarter Results 18IDEXX Laboratories Announces Second Quarter Results 19IDEXX Laboratories Announces Second Quarter Results 20IDEXX Laboratories Announces Second Quarter Results 21IDEXX Laboratories Announces Second Quarter Results 22IDEXX Laboratories Announces Second Quarter Results 23IDEXX Laboratories Announces Second Quarter Results 24IDEXX Laboratories Announces Second Quarter Results 25IDEXX Laboratories Announces Second Quarter Results 26IDEXX Laboratories Announces Second Quarter Results 27IDEXX Laboratories Announces Second Quarter Results 28IDEXX Laboratories Announces Second Quarter Results 29Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 2Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 3Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 4Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 5Unilife Announces Multifaceted Financing Strategy 2Unilife Announces Multifaceted Financing Strategy 3Unilife Announces Multifaceted Financing Strategy 4
... - Trial Results Confirm Efficacy for Population ... N.J. and EMERYVILLE, Calif., May 16 ,Bayer ... ONXX ) today announced that Nexavar(R) ... percent (HR=0.68;,p-value=0.014) in patients in the Asia-Pacific ...
... Ovarian ... Cancers -, - Company ... SOUTH SAN FRANCISCO, Calif., May 15 Poniard,Pharmaceuticals, Inc. (Nasdaq: ... will present data from three,clinical trials of picoplatin, in various tumor types ...
Cached Medicine Technology:Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 2Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 3Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 4Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 6Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 2Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 3Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 4Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 5
(Date:7/30/2015)... , ... July 30, 2015 ... ... a video, “Beachside Nursing Center,” to announce its position as one of ... Beachside's administrator and staff members support the CMS rating system, which monitors ...
(Date:7/30/2015)... ... July 30, 2015 , ... Zejax is a New ... Increases Training Capability , World renown body weight trainer, Paul Ziachik, announces ... that dramatically increases a person’s training capability. , The American College of Sports ...
(Date:7/30/2015)... ... 2015 , ... Boston Web Marketing is proud ... Partners is the platform for search marketing agencies to communicate with the Google ... to run successful search marketing campaigns. Google Partners also affords businesses the opportunity ...
(Date:7/30/2015)... ... 2015 , ... Gummy smile surgeon, Dr. Alex Farnoosh, now offers ... well as the patented gum depigmentation treatmet. Dr. Farnoosh is a renowned dentist with ... from around the world. , “Like treatment of any other disease or condition, making ...
(Date:7/30/2015)... ... ... InventHelp, a leading inventor service company, announces that one of its ... to apply lotion or medication to a hard-to-reach area. This invention is patented. , ... to the back, and provides thorough coverage. The product would prevent the user from ...
Breaking Medicine News(10 mins):Health News:Beachside Nursing Center Releases New Video 2Health News:Zejax is a Revolutionary New Way of BodyWeight Training Without Weights 2Health News:Boston Web Marketing Attends Google Partners All-Stars Summit 2Health News:Gummy Smile Dentist, Alex Farnoosh DMD, is Now Offering Comprehensive Treatment Options for Gummy Smiles 2Health News:InventHelp® Client Patents “My Back Buddy” – Device Could Apply Lotion to Hard-to-Reach Areas Easily 2
... 40 percent of new moms aren,t married, CDC reports ... of unmarried women having children has risen sharply in the ... officials. , In the United States, 40 percent of births ... to women in their 20s, not teenagers, according to a ...
... The beta-carotene in so-called "Golden Rice" converts to vitamin ... Medicine (www.bcm.edu) and Tufts University in an article that appears ... Clinical Nutrition . , Golden Rice was developed ... Foundation with the goal of creating rice that had beta-carotene ...
... Department Nurses for Role in Prestigious DesignationEMERYVILLE, Calif., ... of the nation,s largest providers of emergency department ... its client, Palomar Pomerado Health (PPH) system, has ... Center (ANCC). Only five percent of U.S. hospitals ...
... discussion about trade-offsSTANFORD, Calif., May 13 Americans ... involved in health care reform, according to new ... Longevity (SCL).The findings are the result of a ... and united the typically disconnected worlds of politics, ...
... Sharing Miracles, a 30-minute public affairs television program ... patients has expanded its reach across America, now airing ... The current episode features nine-time NBA all-star and Basketball ... year, the Sharing Miracles network has expanded ...
... ST. LOUIS, May 13 Express Scripts, Inc. (Nasdaq: ... Deutsche Bank 34th Annual Health Care Conference on May 19, ... Boston. This presentation will also be broadcast via the Internet ... Express Scripts web site at http://www.express-scripts.com . RealPlayer ...
Cached Medicine News:Health News:More Single Women Are Having Babies 2Health News:More Single Women Are Having Babies 3Health News:More Single Women Are Having Babies 4Health News:Palomar Pomerado Health System Achieves National Recognition for Nursing Excellence by the American Nurses Credentialing Center 2Health News:Palomar Pomerado Health System Achieves National Recognition for Nursing Excellence by the American Nurses Credentialing Center 3Health News:Stanford Center on Longevity Releases New Findings About Voter Attitudes on Health Care Reform 2Health News:'Sharing Miracles' Television Program Now Airs on More Than 300 Stations 2Health News:'Sharing Miracles' Television Program Now Airs on More Than 300 Stations 3Health News:'Sharing Miracles' Television Program Now Airs on More Than 300 Stations 4Health News:'Sharing Miracles' Television Program Now Airs on More Than 300 Stations 5Health News:'Sharing Miracles' Television Program Now Airs on More Than 300 Stations 6Health News:'Sharing Miracles' Television Program Now Airs on More Than 300 Stations 7
... The SmartCycler System is a rapid, real-time ... prepared biological samples. By automating much of ... site individually programmable, it is the fastest, ... now on the market. The SmartCycler delivers ...
... The LightCycler 2.0 System is the newest ... Science. This new instrument offers six detection ... 560, 610, 640, 670, and 710nm. Perform ... by air and working with glass capillaries. ...
Mx3000P instrument, desktop computer, Mx3000P software package, user's manual, one Brilliant QPCR Reagent of your choice, and custom filter wheel with 4 filters chosen from: FAM/SYBR Green I, TET, HE...
... Stratagene delivers a new standard in QPCR ... This new system offers superior performance, more ... unit, Computer system - with Windows 98SE ... Keyboard, Mouse, Premier Sound Speakers, Surge Protector ...
Medicine Products: